Pressroom

Fresh Meadows, NY, February 3, 2021–Data Conversion Laboratory (DCL), a leader in structured data and content transformations, and Generis, a leader of world-class, cloud-hosted content and regulatory information management solutions, today announce a strategic global partnership that enables life sciences and other regulated industries to accelerate structured content authoring (SCA) and structured content management (SCM) initiatives for both current and legacy documents.

Information accuracy, traceability, and compliance are critical in life sciences, along with speed to market. DCL helps businesses organize and structure data and content for use and reuse in new ways across modern technologies and platforms.  A long-time industry leader in Structured Product Labelling (SPL) conversion services for global pharma companies, DCL now empowers organizations to go beyond merely meeting government guidelines. By improving content structure and data management  throughout the drug development life cycle, organizations achieve workflow efficiencies while also improving patient outcomes.

This partnership enables clients to reduce dependencies on legacy systems and transform the way they interact with content. Leveraging Generis’s flagship CARA™ Life Sciences Platform, organizations can streamline business processes by combining structured content and component-based authoring, review, approval, and publishing with audit trails on a single, user-friendly platform.

“This collaboration represents a great meeting of minds,” states Mark Gross, President at DCL. “Generis’s innovative structured content authoring technology solves complex content and information management problems faced by life sciences as well as other regulated enterprises. By combining our respective solutions, the partnership allows clients to adopt an end-to-end structured content authoring process that bridges the gap between departments to create a continuous workflow and a better user journey.”

DCL’s ability to reliably convert legacy information into useable formats enables comprehensive use of structured content authoring with Generis’s CARA platform. True digital transformation empowers organizations to maximize content interchange, streamline workflows, and process information efficiently and accurately. DCL also provides strategic guidance and tools to clients as they evaluate existing content, to rapidly identify the potential value from content reuse and where to focus conversion efforts.

“Transforming legacy content into useable formats for structured content authoring benefits clients working in a range of sectors including life sciences,” explains James Kelleher, Founder and CEO at Generis. “DCL is fluent across all content types and industry standards and we are thrilled to partner with such a progressive organization.”